Target Details
| UniProt AC | P22607 |
|---|---|
| Gene Symbol | FGFR3 |
| Protein Name | Fibroblast growth factor receptor 3 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF21165 (FGFR3_TM) PF07679 (I-set) PF13927 (Ig_3) PF07714 (PK_Tyr_Ser-Thr) |
Summary
- Multi-target molecules 2,742
- Clinical molecules 64
- Avg pChEMBL 7.75
KEGG Pathways (13)
- Bladder cancer
- Calcium signaling pathway
- Central carbon metabolism in cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocytosis
- MAPK signaling pathway
- MicroRNAs in cancer
- PI3K-Akt signaling pathway
- Pathways in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Signaling pathways regulating pluripotency of stem cells
Associated Diseases (15)
- Achondroplasia
- Bladder cancer
- CATSHL syndrome
- Colorectal cancer
- Crouzon syndrome
- Epidermal nevus
- FGFR3-related short limb skeletal dysplasia
- Hypochondroplasia
- Lacrimo-auriculo-dento-digital syndrome
- Muenke syndrome
- Multiple myeloma
- SADDAN
- Syndromic craniosynostoses
- Testicular cancer
- Thanatophoric dysplasia
Active Molecules (2,742)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
ONINVXNOMWDCJH
|
8.4 | IC50 | 3 | — | |
WPVIYTSQVGVPEE
|
8.4 | IC50 | 3 | — | |
YHYVUGXKQJNEDM
|
8.4 | IC50 | 3 | — | |
BZFULTDZKYXUOC
|
8.4 | IC50 | 5 | — | |
FWIRJQMGGXJLNW
|
8.4 | IC50 | 5 | — | |
GEWSAWDDUPCBQS
|
8.4 | IC50 | 2 | — | |
IANNGBSXAWBFAQ
|
8.4 | IC50 | 2 | — | |
JPLDHAFUWHHECK
|
8.4 | IC50 | 2 | — | |
MUEXACBVOKHMHK
|
8.4 | IC50 | 2 | — | |
WRABCNDMFRHWIR
|
8.4 | IC50 | 6 | — | |
YEIRROBVFZDCIW
|
8.4 | IC50 | 7 | — | |
BINZKUIUUZZJSK
|
8.3 | IC50 | 3 | — | |
KJGQZAPNEIXLDS
|
8.3 | IC50 | 3 | — | |
NTPSXOIFCGNPHC
|
8.3 | IC50 | 3 | — | |
UJGBKUMKLLDSQI
|
8.3 | IC50 | 5 | — | |
VGVUCVKLHHCRRJ
|
8.3 | IC50 | 5 | — | |
WTMSECTVVFONAK
|
8.3 | IC50 | 2 | — | |
XSQABTCRYMWCRL
|
8.3 | IC50 | 3 | — | |
YCDXQAMENDICNP
|
8.3 | IC50 | 2 | — | |
ZZTNIXAOUAZNRE
|
8.3 | IC50 | 3 | — | |
BXBWZDDZLDSYQH
|
8.3 | IC50 | 5 | — | |
DOUKVHHXGYUDNB
|
8.3 | IC50 | 2 | — | |
IHIQKRYMXUFAGS
|
8.3 | IC50 | 5 | — | |
KJBNGJWFSNGUGW
|
8.3 | IC50 | 2 | — | |
NRBSFHSUWBAYCI
|
8.3 | IC50 | 5 | — | |
PDCHXVOBVIQUEZ
|
8.3 | IC50 | 5 | — | |
PLKAJXMYXBXIGX
|
8.3 | IC50 | 7 | Yes | |
RALRANHRVZDLCX
|
8.3 | IC50 | 3 | — | |
RVDYKGWQZZBPJX
|
8.3 | IC50 | 2 | — | |
UDKMUAXCBDODJH
|
8.3 | IC50 | 6 | — | |
VJGVQTRRTNVNTM
|
8.3 | IC50 | 3 | — | |
XHCHGZHSYDYRKE
|
8.3 | IC50 | 3 | — | |
XMAIAGUHQHUOKQ
|
8.3 | IC50 | 3 | — | |
YULXUQHIJIGLND
|
8.3 | IC50 | 2 | — | |
CGFYKMPVFSVIHD
|
8.3 | IC50 | 2 | — | |
MNGPWOAYMBPUSQ
|
8.3 | IC50 | 5 | — | |
UMBCDTSTLGNZAT
|
8.3 | IC50 | 3 | — | |
WJZSUSVUKVZGLF
|
8.3 | IC50 | 7 | Yes | |
IVQXFJNVCKJIHX
|
8.3 | IC50 | 5 | — | |
MEKRRNGBDAULRT
|
8.3 | IC50 | 3 | — | |
MMLFVTVEIJMQEK
|
8.3 | IC50 | 2 | — | |
VHFMHBIMCJDKNP
|
8.3 | IC50 | 2 | — | |
GEMHNNGOAKEHGC
|
8.3 | IC50 | 2 | — | |
GYNREAFZDKMQML
|
8.3 | IC50 | 3 | — | |
GYSNMOKUABWZLQ
|
8.3 | IC50 | 3 | — | |
IBRJKAVHCWQUPP
|
8.3 | IC50 | 3 | — | |
MBJSTRUZPYRLFI
|
8.3 | IC50 | 2 | — | |
QCYDLOHINRAHID
|
8.3 | IC50 | 5 | — | |
QFUNEGRJTMMWQQ
|
8.3 | IC50 | 3 | — | |
QKLROYVFWRSBCK
|
8.3 | IC50 | 2 | — |